Literature DB >> 28695474

Statin Therapy and Risk of Intracranial Hemorrhage in Patients with Ischemic Stroke.

Matilda Florentin1, Moses S Elisaf2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28695474     DOI： 10.1007/s40264-017-0570-x

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  32 in total

1.  Use of statin during hospitalization improves the outcome after intracerebral hemorrhage.

Authors:  Yue-Song Pan; Jing Jing; Yi-Long Wang; Xing-Quan Zhao; Bo Song; Wen-Juan Wang; David Wang; Gai-Fen Liu; Li-Ping Liu; Chun-Xue Wang; Yong-Jun Wang
Journal:  CNS Neurosci Ther       Date:  2014-04-21       Impact factor: 5.243

2.  High-dose atorvastatin after stroke or transient ischemic attack.

Authors:  Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

3.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.

Authors:  Martin J O'Donnell; Denis Xavier; Lisheng Liu; Hongye Zhang; Siu Lim Chin; Purnima Rao-Melacini; Sumathy Rangarajan; Shofiqul Islam; Prem Pais; Matthew J McQueen; Charles Mondo; Albertino Damasceno; Patricio Lopez-Jaramillo; Graeme J Hankey; Antonio L Dans; Khalid Yusoff; Thomas Truelsen; Hans-Christoph Diener; Ralph L Sacco; Danuta Ryglewicz; Anna Czlonkowska; Christian Weimar; Xingyu Wang; Salim Yusuf
Journal:  Lancet       Date:  2010-06-17       Impact factor: 79.321

4.  Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.

Authors:  Valerio Sanguigni; Pasquale Pignatelli; Luisa Lenti; Domenico Ferro; Alfonso Bellia; Roberto Carnevale; Manfredi Tesauro; Roberto Sorge; Renato Lauro; Francesco Violi
Journal:  Circulation       Date:  2005-02-01       Impact factor: 29.690

5.  Total and high-density lipoprotein cholesterol and stroke risk.

Authors:  Yurong Zhang; Jaakko Tuomilehto; Pekka Jousilahti; Yujie Wang; Riitta Antikainen; Gang Hu
Journal:  Stroke       Date:  2012-04-10       Impact factor: 7.914

Review 6.  Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis.

Authors:  Pierre Amarenco; Julien Labreuche; Philippa Lavallée; Pierre-Jean Touboul
Journal:  Stroke       Date:  2004-10-28       Impact factor: 7.914

Review 7.  Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease.

Authors:  Mervyn D I Vergouwen; Rob J de Haan; Marinus Vermeulen; Yvo B W E M Roos
Journal:  Stroke       Date:  2008-01-03       Impact factor: 7.914

8.  Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage.

Authors:  Satu Mustanoja; Daniel Strbian; Jukka Putaala; Atte Meretoja; Sami Curtze; Elena Haapaniemi; Tiina Sairanen; Ronja Hietikko; Joonas Sirén; Markku Kaste; Turgut Tatlisumak
Journal:  Stroke       Date:  2013-06-11       Impact factor: 7.914

Review 9.  Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.

Authors:  Robert Krysiak; Boguslaw Okopień; Zbigniew Herman
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials.

Authors:  James S McKinney; William J Kostis
Journal:  Stroke       Date:  2012-05-15       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.